These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28278301)

  • 1. GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.
    Whitehead J; Horby P
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005439. PubMed ID: 28278301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
    Manchon P; Belhadi D; Mentré F; Laouénan C
    BMC Med Res Methodol; 2021 May; 21(1):98. PubMed ID: 33952195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
    Karrison TG; Maitland ML; Stadler WM; Ratain MJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1455-61. PubMed ID: 17895472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration.
    Burback D; Molnar FJ; St John P; Man-Son-Hing M
    Dement Geriatr Cogn Disord; 1999; 10(6):534-40. PubMed ID: 10559571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical comparison of group-sequential and adaptive designs.
    Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
    J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model.
    Ades AE; Lu G; Madan JJ
    Value Health; 2013; 16(1):185-94. PubMed ID: 23337230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim analyses and stopping rules in cancer clinical trials.
    Whitehead J
    Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating relative risks in multicenter studies with a small number of centers - which methods to use? A simulation study.
    Pedroza C; Truong VTT
    Trials; 2017 Nov; 18(1):512. PubMed ID: 29096682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.
    Watson M; Brookes ST; Faulkner A; Kirwan J
    Cochrane Database Syst Rev; 2007 Jul; 2006(1):CD000142. PubMed ID: 17636601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.
    Whitehead J; Horby P
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006414. PubMed ID: 29652883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial Sequential Analysis in systematic reviews with meta-analysis.
    Wetterslev J; Jakobsen JC; Gluud C
    BMC Med Res Methodol; 2017 Mar; 17(1):39. PubMed ID: 28264661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies of testing for syphilis during pregnancy.
    Shahrook S; Mori R; Ochirbat T; Gomi H
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010385. PubMed ID: 25352226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.